Literature DB >> 7852496

Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation.

R Azziz1, E L Bradley, H D Potter, L R Boots.   

Abstract

Some investigators have suggested that "dysregulation" of cytochrome P450c17 alpha may result in the exaggerated secretion of ovarian androgens in hyperandrogenism. Although the majority of hyperandrogenic (HA) patients demonstrate an ovarian source for their androgens, approximately 50% also display adrenocortical hyperactivity and adrenal androgen excess. To determine whether 17-hydroxylase (17-OH) and/or 17,20-lyase dysregulation is responsible for the adrenocortical abnormalities noted in many HA patients, we studied 92 consecutive women with hirsutism and/or HA oligomenorrhea; 26 healthy eumenorrheic nonhirsute women served as controls. The basal levels of total and free testosterone (T), sex hormone-binding globulin, and dehydroepiandrosterone sulfate were measured, and pregnenolone, 17-hydroxypregnenolone, progesterone, 17-hydroxyprogesterone, dehydroepiandrosterone, and androstenedione were measured 0 and 60 min after the acute iv administration of ACTH-(1-24). Controls and HA patients did not differ in mean age or body mass, but HA women had higher basal T, free T, dehydroepiandrosterone sulfate, androstenedione, and LH/FSH and lower sex hormone-binding globulin levels. The mean estimated basal 17-OH activity was higher among HA patients than in controls. Although 52 HA patients demonstrated solely an exaggerated basal delta 5-17-OH activity estimate, few HA patients had an exaggerated estimate for either basal delta 4-17-OH or ACTH-stimulated 17-OH activity. No HA patient demonstrated an exaggerated 17,20-lyase basal activity, whereas 14 demonstrated an exaggerated delta 4-17,20-lyase ACTH-stimulated activity only. There was no association between these estimates of 17-OH and 17,20-lyase activities and the circulating adrenal androgen levels in HA women. Importantly, none of the patients demonstrated an increase in the basal activities of both 17-OH and 17,20-lyase, and only 4 patients demonstrated an exaggerated ACTH-stimulated activity of both 17-OH and 17,20-lyase. In conclusion, the steroidogenic profile observed in this population of HA women before and after ACTH-(1-24) stimulation is not consistent with dysregulation of cytochrome P450c17 alpha and probably represents a generalized alteration of adrenocortical control or biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7852496     DOI: 10.1210/jcem.80.2.7852496

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  Adrenal hyperandrogenism in the pathophysiology of polycystic ovary syndrome.

Authors:  E Carmina; R A Lobo
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

2.  Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome.

Authors:  Kevin H Maas; Sandy Chuan; Evan Harrison; Heidi Cook-Andersen; Antoni J Duleba; R Jeffrey Chang
Journal:  Fertil Steril       Date:  2016-07-26       Impact factor: 7.329

Review 3.  Differential activity of the corticosteroidogenic enzymes in normal cycling women and women with polycystic ovary syndrome.

Authors:  Márcia Marly Winck Yamamoto; Sebastião Freitas de Medeiros
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

4.  Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by apparently idiopathic hirsutism.

Authors:  R Rossi; L Tauchmanovà; A Luciano; R Valentino; S Savastano; C Battista; M Di Martino; G Lombardi
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

5.  Genetics of polycystic ovary syndrome.

Authors:  N Prapas; A Karkanaki; I Prapas; I Kalogiannidis; I Katsikis; D Panidis
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

6.  Impact of obesity on the risk for polycystic ovary syndrome.

Authors:  Bulent O Yildiz; Eric S Knochenhauer; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2007-10-09       Impact factor: 5.958

7.  Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism?

Authors:  F Orio; S Palomba; T Cascella; L Tauchmanovà; S Di Biase; D Labella; T Russo; M Pellicano; S Savastano; F Zullo; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

Review 8.  Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style?

Authors:  J Holte
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 9.  The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies.

Authors:  R B Barnes
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

10.  Bilateral Adrenal Hyperplasia as a Possible Mechanism for Hyperandrogenism in Women With Polycystic Ovary Syndrome.

Authors:  Evgenia Gourgari; Maya Lodish; Meg Keil; Ninet Sinaii; Evrim Turkbey; Charalampos Lyssikatos; Maria Nesterova; Maria de la Luz Sierra; Paraskevi Xekouki; Divya Khurana; Svetlana Ten; Adrian Dobs; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2016-06-23       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.